Gut Liver.
2018 Nov;12(6):609-610. 10.5009/gnl18418.
Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. dyk1025@yuhs.ac
- KMID: 2427448
- DOI: http://doi.org/10.5009/gnl18418
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting
- Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea
- Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
- A Case of Coinfection of Hepatitis A and E Virus with Hepatic Encephalopathy
- Prevention of Viral Hepatitis and Vaccination
